FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34938611000001104: Tadalafil 10mg tablets (Aspire Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105922501000001115 Tadalafil 10mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105922601000001116 Tadalafil 10mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Is a Product containing precisely tadalafil 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has active ingredient Tadalafil false Inferred relationship Existential restriction modifier 1
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has basis of strength substance Tadalafil true Inferred relationship Existential restriction modifier 1
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has presentation strength numerator value 10 false Inferred relationship Existential restriction modifier 1
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Tadalafil 10mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has specific active ingredient Tadalafil true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Tadalafil 10mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tadalafil 10mg tablets (Aspire Pharma Ltd) 4 tablet 2 x 2 tablets Has AMP True Tadalafil 10mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start